skip to content

For staff

A collage of images of cancer patients, researchers and nurses

The Cambridge Cancer Research Hospital (CCRH) project has now had the first stage of its business case approved.

The approval of the Strategic Outline Case by the Department for Health and Social Care and NHS England & NHS Improvement provides backing for the CCRH scheme as part of the government’s commitment to build 40 new hospitals by 2030, with construction set to begin in 2023.

CCRH is a partnership between Cambridge University Hospitals and the University of Cambridge to build a new specialist cancer hospital. It will combine cutting-edge NHS clinical space with three new research institutes that will support the ambitions set out in the government's Life Science Strategy and the NHS Long Term Plan. The new seven storey, 26,000 m2 building will be situated on Europe’s leading life sciences campus, the Cambridge Biomedical Campus.

Bringing together world-class NHS clinicians with cutting-edge University and industry-led research, CCRH will accelerate the early detection of cancer and lead the way in delivering bespoke, precision treatments that will radically improve patient outcomes. 

CCRH will be a one-of-a-kind research hospital and will support the government’s ambitions to enable more early diagnosis and help the UK become a ‘testbed for oncology innovation’.

Additional fundraising and philanthropy will be needed, but the approval of the Strategic Outline Case marks an important milestone for these ambitious plans. We expect to submit the next stage of the business case process - the Outline Business Case - in early 2022. Construction on CCRH is expected to finish in 2025/26.

You can read the full story online.


08 December 2021